Ignite Creation Date:
2025-12-24 @ 7:47 PM
Ignite Modification Date:
2026-01-01 @ 1:07 AM
Study NCT ID:
NCT04659603
Status:
TERMINATED
Last Update Posted:
2025-10-01
First Post:
2020-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-19
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-02
First Submit QC Date:
None
Study First Post Date:
2020-12-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-19
Results First Submit QC Date:
None
Results First Post Date:
2025-03-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-11
Last Update Post Date:
2025-10-01
Last Update Post Date Type:
ESTIMATED